Journal for ImmunoTherapy of Cancer (Nov 2020)

304 Intratumoral injection of CMP-001, a toll-like receptor 9 (TLR9) agonist, in combination with pembrolizumab reversed programmed death receptor 1 (PD-1) blockade resistance in advanced melanoma

  • Kim Margolin,
  • Antoni Ribas,
  • Riyue Bao,
  • Adil Daud,
  • Mohammed Milhem,
  • Elizabeth Buchbinder,
  • Geoffrey Gibney,
  • Jason Luke,
  • Takami Sato,
  • David Mauro,
  • Yousef Zakharia,
  • Theresa Medina,
  • John Kirkwood,
  • Jiaxin Niu,
  • Katie Campbell,
  • George Weiner,
  • Inderjit Mehmi,
  • Heather Kelley,
  • James Wooldridge

DOI
https://doi.org/10.1136/jitc-2020-SITC2020.0304
Journal volume & issue
Vol. 8, no. Suppl 3

Abstract

Read online

No abstracts available.